The briefing
Bayer will invest $2.2 billion to build a new pharmaceutical facility in New Albany, Ohio. The site will focus on therapies for cancer, cardiovascular, and kidney conditions, creating about 600 permanent roles and 1,500 construction jobs during build-out.
Original headline
Germany's Bayer to invest $2.2 billion in US pharma site